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Drug Analysis
Shaza W. Shantier
Abstract
Instrumental methods are widely used for the analysis and stability studies of 
compounds in bulk and pharmaceutical forms. They vary in their sensitivity, tech-
niques and reagents involved. This chapter will overview those different techniques 
and the application of the analytical methods. It will also describe how to design 
and develop simple, sensitive and accurate method for routine quality control of 
specified compound depending on its molecular structure. Quality control and 
assurance of the analytical process will be discussed. Furthermore, the chapter 
will describe a number of factors affecting the chemical and physical stability of 
Pharmaceutical formulations and how to develop stability-indicating methods to 
qualify and quantify the drug degradation.
Keywords: instrumental, development, quality control, validation, stability
1. Introduction
Drug discovery and development process can be divided into two major stages: 
drug discovery which involves isolation of the active constituent, purified, and 
standardized. The second major stage, drug development, starts with a solitary 
compound, which at that point progresses through different studies intended to 
support its endorsement as a new drug [1]. The new drug will then be formulated as 
an appropriate pharmaceutical dosage form.
Pharmaceutical product is medicine intended for human or veterinary use 
in cure, alleviation, prevention or diagnosis of disease. The use of ineffective, 
harmful or poor-quality drugs will cause health hazards and waste of funds. The 
problem is aggravated by adverse climatic conditions and weak drug supply sys-
tem (including storage and transport). These lead to deterioration of drug quality, 
loss of activity and may be formation of harmful degradation products [2]. All 
this made it a must that any pharmaceutical product should be subjected to differ-
ent analytical procedures in order to ensure its efficacy and safety. Therefore, an 
effective drug quality assurance and assessment system should be developed and 
maintained.
2. Pharmaceutical analysis
Broadly speaking, this is the application of a process in order to identify a drug 
(single or combined) in its bulk or pharmaceutical dosage form. Testing phar-
maceutical product involves chemical, physical and sometimes microbiological 
analysis [3].
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Pharmaceutical analysis can be divided into two types of methods:
a. Qualitative methods: these methods usually are used to ascertain the presence 
or identity of a component and\or impurities (predicted or expected).
b. Quantitative methods: determine how much of known drugs are present in 
bulk form or in a formulation.
Since the judgment for quality of a drug depends on the method of analysis 
used, the validity or control of the method used is required. The methods used in 
pharmaceutical analysis should be capable of:
a. Correct identification of the drug in bulk form or as a formulated product.
b. Indicating the percentage of the stated content of a drug present in formula-
tion within acceptable stated limits.
c. Indicating the stability of the drug in the formulation and hence the shelf life 
i.e. indicating the presence of a drug in its intact form and or the presence of 
any impurities (whether as drug precursors, decomposition products due to 
chemical or photochemical causes).
d. Application in the dissolution rate studies i.e. at what rate is the drug released 
from its formulation so that can be absorbed by the body (bioavailability studies).
e. Ensuring that the identity and purity of pure drug (bulk form) meet official 
standards or monograph.
f. Ensuring that the identity and purity of excipients used in formulation meet 
specifications set by official standards.
g. Indicating the concentration of the specified impurities in the pure drug 
substance (limit test application).
3. Drug stability
The stability of a pharmaceutical product is defined as the capability of the 
product, in a specific container, to retain its efficacy, properties and characteristics 
throughout its shelf-life [4]. The recommended shelf-life (expiry date) for a com-
mercial pharmaceutical product is 3–5 years. During this time, the concentration 
of the drug should not be reduced more than 95% of its value when originally 
prepared [5].
There are five types of stability that concern the pharmacist in the manufactur-
ing of drugs:
a. Chemical (including photochemical): the product retains its chemical integrity 
and potency.
b. Physical: the conformity of the pharmaceutical product (color, appearance, 
dissolution, etc.) does not change upon storage or handling.
c. Microbiological: sterilized products should remain sterile (no pyrogenicity).
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d. Therapeutic: the therapeutic effect remains unchanged within the specified 
dosage regimen.
e. Toxicological: no significant increase in a predetermined toxicity effect is noted.
Stability types (therapeutic, microbiological, and toxicological) are basically 
dependent on the chemical and physical properties of the drug.
Knowledge of the chemical stability of a drug is of great concern for 
selecting suitable storage condition against the effects of light, temperature, 
humidity, etc. and for anticipation of drugs interaction with each other or with 
excipients [6, 7].
A stable drug is of great concern to the pharmacist (in view of marketing, stor-
age and distribution); to the physician and patient (in view of safety and efficacy); 
and to the regulator and quality control analyst (in view of quality, strength, purity 
and identity).
3.1 Chemical reactions that cause drug degradation
Many drugs are derivatives of carboxylic acid or contain functional groups based 
on this moiety, for example esters, amides, lactones, lactams, imides or carbamates 
[5]. Accordingly, various chemical reactions can result in the degradation of the 
drug. These reactions include hydrolysis, oxidation, photochemical reactions, 
polymerization, isomerization, racemization and dehydration [4, 5, 8].
3.1.1 Hydrolysis (or solvolysis)
Hydrolysis forms the most common pathway by which drugs become degraded 
since many drugs contain hydrolysable functional groups. It can be defined as the 
process by which drug molecules interact with water to yield breakdown products 
of different chemical constitution. Hydrolysis occurs more readily in liquid state 
than in the solid state. It may occur in aqueous suspensions of sparingly soluble 
drugs. In tablets and other solid dosage forms, there may be sufficient water to 
allow hydrolysis of the drug [8].
Solvolysis is a term used for the reactions involving the decomposition of the 
active drugs with their solvent present (not water).
3.1.2 Ester hydrolysis
Hydrolysis of drugs with an ester functional group (e.g. procaine, atropine, etc.) 
forms one of the most common types of drug instability. It is usually a bimolecular 
reaction involving acyl-oxygen cleavage. Ester hydrolysis is (H+) or (OH−) ion 
catalyzed and is dependent on the specific compound and the pH of the solution. 
Atropine hydrolysis is totally pH dependent and this was characterized by the slopes 
of −1 and +1. In some cases, the hydrolysis of the drug can show a pH-profile with 
three regions: a hydrogen ion (proton) catalyzed region, (slope = −1), an uncata-
lyzed region (solvent dependent, slope = 0) and a hydroxyl ion-catalyzed region 
(slope = +1) (Figure 1) [5].
3.1.3 Amide hydrolysis
Amides are generally more stable to hydrolysis than esters. In general the rate 
of hydroxyl ion-catalyzed reaction of amides is greater than the proton-catalyzed 
hydrolysis [6].
Pharmaceutical Formulation Design - Recent Practices
4
Penicillins and cephalosporins are amides in which the amide bond is part of 
the strained four membered ß-lactam rings. Their decomposition is catalyzed by 
hydrogen ion, hydroxyl ion and many buffers. Therefore, these compounds are too 
unstable to be formulated as solutions. Their pH profile is generally similar to the 
pH-profile shown in Figure 1.
In addition to acid-base catalyzed hydrolysis, enzyme-catalyzed hydrolysis may 
take place in drugs of natural origin; for example enzymes catalyzes the hydrolysis 
of cardiac glycosides in digitalis leaf [8].
3.1.4 Oxidation
Oxidation involves the removal of an electropositive atom, radical or 
electron, or the addition of an electronegative atom or radical. When a reac-
tion involves molecular oxygen (O▬O), it is commonly called autoxidation 
and this forms the most common pathway of oxidative decomposition of 
pharmaceuticals.
Oxidative degradation by autoxidation may involve chain processes consisting 
of three concurrent reactions—initiation, propagation and termination. Initiation 
can be via free radicals formed from organic compounds by the action of light, heat 
or transition metals such as copper and iron which are present in trace amounts in 
almost every buffer [5].
Many drugs are complex molecules and can be subjected to both hydrolysis and 
oxidation e.g. steroids, anti-inflammatory, polyene antibiotics (amphotericin B) etc.
Figure 2 show the oxidation of phenothiazines to the sulfoxide which involves 
two single-electron transfer reactions involving a radical cation intermediate. The 
sulfoxide is subsequently formed by reaction of the cation with water [5].
Oxidation in solution generally follows first or second order kinetics. Some 
oxidation reactions are redox reactions that involve the loss of electrons without the 
addition of oxygen e.g. oxidation of ascorbic acid, ferrous sulfate, adrenaline and 
riboflavin [8].
In addition to oxidation and hydrolysis, many other degradative reactions had 
been studied including addition, dehydration, polymerization, isomerization, 
acylation, transesterification, etc.
Figure 1. 
Log rate-pH profile for the degradation of atropine at 60°C.
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3.1.5 Photochemical degradation
These are the reactions that take place by absorption of the visible or ultraviolet 
light. The reactant molecule absorbs photons of light (energy) and get excited. The 
excited molecule then produces the photodecomposition product.
In many photochemical reactions, the reactant molecule may not absorb the 
radiation directly but through a mediator which absorbs the incident radiation and 
subsequently transfers its energy to the reactant molecule that becomes activated. 
Such type of mediator is called photosensitizer.
At times, a molecule can act as a protector for the photolabile drug by prefer-
entially absorbing the radiant energy and produce products. These compounds are 
referred to as screening agents [9].
Figure 2. 
Phenothiazine oxidation process.
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3.1.5.1 Light sources for photodegradation studies
The majority of therapeutic substances are white in appearance, which means 
that they may absorb in the UV region depending on their chemical structure.
Grossweiner, 1989 [10], divided the ultraviolet radiation (UV-R) into three 
sub-bands:
1. UV-C: which ranges between 200 and 290 nm and is termed shortwave 
or far UV. Sunlight at the earth’s surface is devoid of this band due to its 
absorption by molecular oxygen and ozone in the upper atmosphere. 
Artificial radiation sources such as discharge and germicidal lamps and 
welding arcs form the sources of UV-C which are used for forced drug pho-
todegradation studies (stress-conditions). These also cause serious damage 
to the skin and cornea [11].
2. UV-B band: this covers the region 280–320 nm. It causes sunburn, skin cancer 
and other biological effects and it is responsible for the direct photoreaction of 
many chemicals in natural sunlight.
3. UV-A band: this is the long wavelength region from 320 to 400 nm, also called 
near-UV because it is near the visible region.
The most commonly sources for photostability studies include: day light, 
window-glass filtered day light and room light [12]. All these sources can be gener-
ated artificially. The artificial light source should have an output with spectral 
power distribution (SPD) as near as possible to the sunlight. This can be achieved by 
the use of arc lamps and fluorescent tubes.
3.1.5.2 Drug molecules labile to photodecomposition
A number of medicinal products have been studied for their photostability. 
Carbonyl, nitroaromatic and N-oxide functions, aryl halides, alkenes, polyenes and 
sulfides are certain chemical functions that are expected to introduce photoreactiv-
ity [13].
Photodegradation of a drug is considered of practical significance if the com-
pound absorbs light >300 nm and the photodegradation becomes evident in a short 
period.
Factors that govern photochemical reaction rate include aerobic (most reactions 
proceed in presence of oxygen) and anaerobic (N2) conditions, solvents (H2O, 
organic solvents), buffers, temperature, metals, intensity of radiation and spectral 
distribution of light, drug concentration and volume of the sample [14].
Thus, in formulations that contain low drug concentrations, the primary 
photochemical reaction follows first-order kinetics; the kinetics is more compli-
cated at higher concentrations and in the solid state because most of the light is then 
absorbed near the surface of the product.
The mechanisms of photodegradation are of such complexity as to have 
been fully elucidated in only a few cases. For example, the phenothiazine chlor-
promazine (CLP) is rapidly decomposed under the action of ultraviolet light, the 
decomposition being accompanied by discoloration of the solutions (Figure 3). 
Chlorpromazine behaves differently towards ultraviolet irradiation under anaerobic 
conditions.
A polymerization process has been proposed which involves the liberation of 
HCl in its initial stages [5].
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The photodegradation of ketoprofen can involve decarboxylation to form an 
intermediate which then undergoes reduction, or dimerization of the ketoprofen 
itself.
4. Analytical methods
4.1 Method development
Prior the development of any method for the analysis of certain compound 
or formulation, there are many factors must be considered before developing 
the method and applying it to the intended use. The first step include collecting 
information about the analyte itself (the analyte structure and its physicochemical 
properties). The mode of detection should be selected (e.g. UV detection). Sample 
preparation which may include centrifugation, sonication and filtration. The type 
of the diluent also plays an integral role in the analysis as it should be transparent 
and does not interfere in the analysis. The stability of the prepared solution, the 
mobile phase; stationary phase and mode of elution in case of chromatographic 
elution. All these factors and much more should be considered, optimized and the 
developed method is then validated and applied for the analysis.
Figure 3. 
The effect of ultraviolet light on chlorpromazine (CLP).
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4.2 Spectrophotometric methods
4.2.1 UV/VIS spectrophotometry
Absorption spectrophotometry is the measurement of an interaction between 
electromagnetic radiation and the molecules, or atoms, of a chemical substance 
[15]. Techniques frequently employed in pharmaceutical analysis include UV, 
visible, IR and atomic absorption. Spectrophotometric measurement in the visible 
region was referred to as colorimetry.
The procedure of UV-unmistakable spectrophotometry includes the estima-
tion of the measure of bright (190–380 nm) or noticeable (380–800 nm) radiation 
consumed by a substance in arrangement. Retention of light in both the UV and 
unmistakable area of the electromagnetic range happens when the vitality of the 
light matches the vitality required to instigate an electronic change and it is related 
with vibration and rotational progress in the atom. There are two systems of utilizing 
spectroscopic estimations in medication examination, the total and the similar strat-
egies for measure, and the one utilized relies upon which side of the Atlantic Ocean 
you complete the investigation. In the UK and Europe the Beer-Lambert condition 
will in general be utilized in what is known as the outright technique for examine. In 
this strategy the absorbance is estimated tentatively and the Beer-Lambert condition 
is comprehended for c, the medication fixation. Hence, the British Pharmacopeia 
and European Pharmacopeia quote A1% 1 cm qualities in medication monographs. 
In the US Pharmacopeia, the near strategy for test is liked. In this sort of examine a 
standard arrangement of the medication to be investigated is readied, the absorbance 
of the example and the standard are estimated under indistinguishable conditions, 
and the centralization of the example is determined from the relationship:
  Atest _
 [test] 
 =  Astd _
 [std] 
  (1)
Where [test] is the centralization of the example and [std] is the convergence 
of the readied standard. The relative strategy for test has the bit of leeway that 
it very well may be utilized regardless of whether the medication experiences a 
substance response during the measure (for example development of a shaded 
subsidiary to permit estimation in the obvious district of the range), yet experi-
ences the hindrance that a credible example of the medication being referred to 
must be accessible for examination. When doing medication examines by spec-
troscopy it is frequently important to set up a scope of groupings of a standard 
example of the analyte and measure the absorbance of every arrangement. At the 
point when these information are plotted, a straight line of positive incline ought 
to be acquired that goes through the inception. Developing diagrams of this sort 
not just confirms that the Beer-Lambert law applies to the test at the wavelength of 
estimation yet additionally enables the chart to be utilized for alignment purposes. 
An answer of obscure fixation is set up in the very same manner as the benchmarks 
and its absorbance is estimated at a similar wavelength as the principles. This 
absorbance is then perused off the alignment chart and the fixation is determined. 
Standard arrangements arranged independently from the example along these 
lines are known as outer models. An increasingly thorough system includes the uti-
lization of inside models. An inside standard is an exacerbate that is comparative 
in compound structure and physical properties to the example being investigated. 
The inner standard ought to be added to the example being referred to before 
extraction or measure initiates and is then present in the example framework all 
through the consequent test. In the measure of complex examples, some example 
pre-treatment is normally required and the recuperation of the example from the 
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extraction procedure may not be 100%. On the off chance that an inner standard 
is utilized, misfortunes in test will be reflected by comparative misfortunes in the 
standard and the proportion of test to standard ought to stay consistent. Inner 
measures are especially utilized in chromatographic examination (particularly gas 
chromatography and elite fluid chromatography), where fluctuations in instru-
mental parameters (for example flow rate of versatile stage) influence precision. In 
certain spectroscopic examinations a comparable way to deal with the utilization 
of inner benchmarks is utilized. This is the strategy of standard augmentations 
and includes expansion of expanding volumes of a standard arrangement of the 
analyte to a fixed volume of the example and development of an alignment dia-
gram. The diagram in a standard expansion examine is of positive incline however 
converges they-pivot at a positive estimation of absorbance. The measure of medi-
cation in the example is found by extrapolation of the alignment chart back to the 
point where the line crosses the x-pivot (for example at the point when y 0 in the 
condition of the line). The strategy for standard increments is generally utilized in 
nuclear spectroscopy (for example assurance of Ca2+ particles in serum by nuclear 
emanation spectrophotometry) and, since a few aliquots of test are examined 
to create the alignment chart, should expand the exactness and accuracy of the 
measure. The chief advantage of colorimetric and spectrophotometric methods is 
that they provide a simple means for determining minute quantities of substances 
[16, 17]. Although spectral interference (degradation products, excipients, etc.) 
can often occur, the selectivity and sensitivity of these methods can be improved 
by employing an instrumental technique such as derivative spectrophotometry.
4.2.2 Derivative spectrophotometry
In derivative spectrophotometry the absorbance (A) of a sample is differentiated 
with respect to wavelength (λ) to generate the first, second or higher order deriva-
tive [18].
In the context of derivative spectrophotometry, the normal absorption spectrum 
is referred to as the fundamental, zero order or 0D spectrum.
  A = f(λ)  dA/dλ = f(λ) d2A/λ2 = f ∆(λ), etc.
  Zero order first order second derivative
The first derivative (1D) spectrum is a plot of the rate of change of absorbance 
with wavelength against wavelength, i.e. a plot of the slope of the fundamental 
spectrum against wavelength. The second derivative (2D) spectrum is a plot of the 
curvature of the 0D spectrum against wavelength.
The first order derivative spectrum of an absorption band is characterized by a 
maximum, a minimum and a crossover point at λmax of the absorption band. This 
bipolar function is characteristic of all odd-order derivatives.
The second derivative spectrum is characterized by two satellite maxima and an 
inverted band of which the minimum corresponds to the λmax of the fundamental 
band.
A derivative spectrum is therefore gives better resolution of overlapping bands 
than the corresponding fundamental spectrum and may permit the accurate deter-
mination of the λmax of the individual bands. Secondly, it discriminates in favor of 
substances of narrow spectral band width against those with broad bandwidth. And 
consequently, substances with narrow spectral bandwidth display larger derivative 
amplitude than those with broad bandwidth [15].
These advantages of enhanced resolution and band width discrimination found 
in derivative spectrophotometry permit the selective determination of certain 
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absorbing substances in samples in which non-specific interference may limit the 
application of simple spectrophotometric methods. Ephedrine hydrochloride in 
ephedrine hydrochloride elixir is assayed by second derivative spectrophotometry, 
which eliminates the broad band absorption of the excipient.
Derivative spectrophotometry has found significant application in clinical, 
forensic and biomedical analysis. It has been widely applied in the analysis of 
different pharmaceutical dosage forms. It solves the problem of analysis associated 
with drug combination, stability studies of drug and degradation products, drug 
impurities and interference of excipient in drugs [19, 20]. It also solves the problem 
of analysis of drugs in biological fluids.
4.2.3 Difference spectrophotometry
Both selectivity and accuracy of spectrophotometric analysis of samples, which 
contain absorbing interferons, may be greatly improved by the technique of dif-
ference spectrophotometry. In difference spectrophotometry assays the measured 
value is the difference in absorbance (∆A) between two equimolar solutions of the 
analyte, in different chemical forms which exhibit different spectral characteristics. 
It is sometimes referred to as differential spectrophotometry.
Certain criteria are required for applying difference spectrophotometry for the 
analysis of a substance in the presence of other absorbing substances:
1. Reproducible changes are induced in the spectrum of the analyte by the  
addition of one or more reagents.
2. The absorbance of the interfering substances is not altered by the addition of 
such reagents.
The simplest and most commonly used techniques for altering the spectral prop-
erties of the analyte is the adjustment of the pH of the solution by means of aqueous 
solution of acids, alkali or buffers [21]. The measured value (∆A) in a quantitative 
difference spectrophotometric assay can be proportional to the concentration of the 
analyte and so it obeys Beer’s law. A modified equation may be derived.
  ∆A = ∆abc  (2)
Where ∆a is the difference absorptivity of the substance at the wavelength of 
measurement.
The accuracy and selectivity of the method was found to be increased by con-
version of normal zero-order or differential UV spectra into higher order [21, 22]. 
Therefore, the application of difference spectrophotometry is expected to have the 
totality of advantages of both derivative spectrophotometry (first, second, etc.) 
combined with delta spectrophotometry [23].
On the other hand, the stability-indicating property, coupled with the selectivity 
and simplicity of application, of the derivative spectrophotometry (first, second, 
etc.) and ∆D1 make these methods more preferable to use for drug analysis than the 
costly HPLC methods, especially in developing countries.
4.2.4 Colorimetric method
Colorimetric methods, although are generally dependent on functional group 
in the drug molecule (NH2, OH, SH), are sometimes utilized as stability-indicating 
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methods. This can be achieved by selectively transforming a drug, its degradation 
product or its impurity into a derivative so that the spectrum of the derivative is 
shifted to the visible region.
There are several parameters, which require careful and critical consideration 
in colorimetry. Firstly, the color reagent should be selective for the drug molecule 
itself, discriminating degradation products which might be present. Secondly, the 
effect of any parameters which can affect the development and stability of the color 
should be established. Moreover, the time required to establish the chromophore 
should be carefully monitored and assessed.
4.3 Chromatographic methods (HPLC and TLC)
Chromatography is essentially a group of techniques for the separation 
of the compounds of mixtures by their continuous distribution between two 
phases. One of the two phases is the fixed (stationary) phase, which can be 
solid or a liquid supported on a solid. The other phase is a moving (mobile) 
phase which can be gas or a liquid that flows continuously around the station-
ary phase.
According to the nature of the mobile phase, chromatography is subdivided into 
liquid chromatography (LC) where the mobile phase is a liquid, and gas chromatog-
raphy (GC) where the mobile phase is a gas [15].
4.3.1 Liquid chromatography
There are four classifications for liquid chromatography:
a. Adsorption chromatography: liquid solid chromatography (LSC).
b. Partition chromatography: liquid-liquid chromatography (LLC).
c. Ion exchange chromatography: an ionic liquid mobile phase and a solid poly-
meric stationary phase containing replaceable ions.
d. Size-exclusion chromatography.
The adsorption and partition chromatography (most widely used in pharmaceu-
tical analysis) are subdivided to:
a. Column chromatography and thin-layer chromatography (TLC): solid station-
ary phase and liquid mobile phase.
b. Column, paper and thin-layer chromatography: liquid stationary phase and 
liquid mobile phase.
High performance liquid chromatography (HPLC) belongs to the category of 
column chromatography and it covers four classes of chromatography: adsorption 
(LSC), partition (LLC), ion exchange and size-exclusion.
4.3.2 Thin-layer chromatography (TLC)
Thin-layer chromatography has developed into a very sophisticated technique 
for identification of compounds and for determination of the presence of trace 
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impurities. Separation in TLC occurs by either adsorption or partition. For adsorp-
tion, the stationary phase consists of a thin layer of sorbent (e.g. silica) which is 
activated by heating at 105°C to evaporate water and the mobile phase is devoid of 
water (usually a mixture of organic solvents).
The term retention time used in TLC is referred to as Rf value which is the 
distance traveled by the compound from the origin (where the compound is spot-
ted on the plate) divided by the distance traveled by the solvent. Although TLC 
is widely used for qualitative analysis, it does not in general provide quantitative 
information of high precision and accuracy. Changes in the practice of TLC have 
resulted in improved performance of separation and quantitative measurement. 
These developments are referred to as high-performance thin-layer chromatogra-
phy (HPTLC) [24].
TLC is widely used in pharmaceutical analysis for:
a. Identification of the components of a mixture by comparing their Rf values 
with those of reference standard.
b. Detection of any impurities (synthetic route, stability during manufacturing 
process or storage).
c. Separation of a mixture of compounds and recovery by elution technique.
d. Following synthetic reactions for their completion.
e. Forensic application in drug poisoning or addiction.
4.3.3 High performance liquid chromatography (HPLC)
HPLC is the most commonly used technique for the quantification of drugs in 
formulations. The principal advantages of HPLC compared to column chromatogra-
phy are improved resolution of the separated substances, faster separation time and 
the increased accuracy, precision and sensitivity.
HPLC is based on the same separation modes of column chromatography i.e. 
adsorption and partition. Unmodified silica (silanol group) is the most widely used 
in adsorption HPLC. Partition HPLC is divided into two categories, normal-phase 
and reverse-phase, based on the relative polarities of the stationary and mobile 
phases.
In order to develop HPLC method and to select the appropriate column type, the 
analyst needs to know:
a. Suitable solvent for the drug.
b. Molecular structure.
c. Nature of analysis: whether for quantification analysis or stability-indicating 
method.
The following diagram (Figure 4) gives a general guide to the selection of a 
chromatographic method for separation of compounds of molecular weight ˂ 2000; 
for samples of higher molecular weight the method of choice would be size-exclu-
sion [25, 26].
13
Drug Analysis
DOI: http://dx.doi.org/10.5772/intechopen.88739
5. Quality assurance and quality control
In the pharmaceutical Industry, quality management is defined as the aspect of 
management function that determines and implements the quality policy.
The major elements of quality management are:
a. A quality system describing the organizational structure, procedures, pro-
cesses and resources.
b. A systematic action or actions necessary to ensure adequate confidence that a 
product (or service) will satisfy given requirement for quality.
The concepts of quality assurance, GMP and quality control are interrelated 
aspects of quality management. They are inter-related and have fundamental 
importance to the production and control of pharmaceutical products.
In fact quality assurance covers quality control in exactly the same manner as 
it covers other functions such as manufacturing and ware-housing. It approves 
methods and standards and sees to it that good laboratory practices are operative.
Each manufacturing unit must have a quality control department independent 
from the production and other departments and under the control of a qualified 
and experienced personnel and has one or several quality control laboratories at his 
or her disposal.
Quality control is integral part to all modern industrial processes and the 
pharmaceutical industry is not an exception. Testing a pharmaceutical product 
involves physical, chemical and sometimes microbiological analysis. It is a critical 
function of any business offering a product or service to consumers. In the field of 
pharmaceutical chemistry, quality control is vital to the successful development, 
manufacturing, and use of drugs meant to save lives. It determines the quality 
and stability of drug products via pharmaceutical analysis; it includes areas such 
as method validation, handling raw materials and finished products, documenta-
tions, inspections that impact the development of pharmaceutical products that are 
governed by specified rules.
Pharmaceutical products are developed and produced according to GMP 
requirements and other associated codes e.g. good laboratory practices (GLP), and 
good clinical laboratory practices (GcLP), … etc.
Figure 4. 
General guide for selection of chromatographic method.
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Production and control operations are clearly specified in a written form i.e. 
standard operating procedures (SOP’s) and GMP requirements are adopted.
Control procedures on starting materials, intermediate products and finished 
products and other in process controls should be carried out according to written 
and validated procedures.
The finished products should be correctly processed, checked, packed according 
to defined procedures.
Finished pharmaceutical products should not be sold or supplied unless they are 
released by an authorized person.
6.  Method validation and statistical interpretation of the analytical 
method
The function of the analyst is to obtain a result as near to the true value 
as possible by the correct application of the analytical procedure employed. 
Quantitative analysis is not simply a case of taking sample, carrying out a single 
determination and then claim that the value obtained is irrefutable. It also 
requires knowledge of the chemistry involvements and the possibilities of the 
interferences from other ions, elements and compounds as well as of the statisti-
cal distribution of values [27].
Different errors may occur during the analysis process which should be well 
noticed and overcome. There are three types of errors:
a. Gross errors: easily recognized as it leads to definite unreliable results: could be due 
to contaminated reagents, defective instruments, accidental loss of crucial sample 
etc. It is defined as a serious error so that there is no way to correct the experiment.
b. Random error (in determinate error): the average of the results are very close 
to the true value, so there is no evidence of bias i.e. some results could be high 
and some results could be low. Arises from sources that cannot be corrected i.e. 
the degree of sensitivity of the balance: fourth decimal, fifth decimal. Types of 
burettes or pipettes (A, B, C types) etc.
c. Systematic (determinant errors): this causes all the results to be in error in the 
same sense (constant error). May be due to (1) faults in analytical procedure or 
(2) the equipment used. Observed result could be too low or too high i.e. inac-
curacy should be constant (all answers are 10% too high or too low). Example: 
True value for three samples were 25, 20 and 30% assay result was 35, 30 and 
40% respectively i.e. 10% too high. It makes the assay precise but inaccurate 
sometimes the inaccuracy may be proportional to the true answer, giving rise 
to proportional error such as 10% of the answer i.e. for the above example for 
25% result is 27.5%, 22% for 20% and 33% for30%.
Validation of methods for the quantitative analysis of drugs involves determin-
ing as a minimum, their selectivity, and limit of detection, limit of quantification, 
linearity, working range, accuracy and precision [28].
6.1 Accuracy
Accuracy is a measure of how closely the result of an experiment agrees with 
the expected result. The difference between the obtained result and the expected 
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result is usually divided by the expected result and reported as a percent relative 
error [29].
6.2 Precision
Precision is a measure of how close a set of results are to each other [30]. It 
is often measured under repeatable (same analyst, same day, same instruments 
and same materials) and reproducible conditions. Precision always accompanies 
accuracy, but a high degree of precision does not imply accuracy.
6.3 Linearity
For any developed analytical method, standard curve is constructed to verify the 
linear relationship between the concentration and a characteristic parameter for a 
component such as peak area, peak height or peak ratio in chromatographic analysis 
or UV-absorption in spectrophotometry.
Most analytical methods are based on processes where the method produces 
a response that is linear and which increases or decreases linearly with analyte 
concentration. In other words, it is the ability of the method to elicit test results that 
directly proportional to the concentration of analyte within a given range.
Statistical application is important in evaluating calibration graphs in instru-
mental analysis. The equation of a straight line takes the form:
  y = a + bx  (3)
Where a is the intercept of the straight line with the y axis and b is the slope of 
the line.
The statistical measure of the goodness of the fit of the line through the data 
is the correlation coefficient “r”. It falls in the range −1 ≤ r ≥+1. Negative r-values 
indicate negative slope and vice-versa. It is important to note that calculated 
r-values can be sometimes misleading and a calibration curve must be physically 
plotted to ensure the shape of the plot. From the calculated regression line data, 
the concentration of the analyte can be estimated by interpolation. Each value of 
y is subjected to random error and likely an error in the slope and intercept values 
can occur. This can be resolved by calculating standard deviations of the slope (Sb) 
and intercept (Sa). Sb and Sa are obtained from a calculated statistic value Sy/x [29]. 
The values of Sb and Sa are used to calculate the confidence limits for the slope and 
intercept using a t-value at a desired confidence level, normally 95% level. These 
limits are important to indicate if there is a significant difference between these 
values and certain true values, which reflects the effect of random or systemic 
errors.
6.4 Limit of detection
The limit of detection is the lowest content of analyte that can be distinguished 
from background noise and measured with reasonable statistical certainty. It can be 
calculated by the reduced formula:
  3SB / b  (4)
Where SB = Sy/x (calculated from the regression analysis data), b is slope [29].
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6.5 Limit of quantification
The lower limit of quantification is the amount equal to or greater than the 
lowest concentration point on the calibration curve that can be measured with an 
acceptable level of accuracy and precision [29].
It can be calculated by the equation:
  10SB / b  (5)
Where SB = Sy/x (calculated from the regression analysis data), b is slope.
6.6 Method comparison
The comparison of two methods should be carried out using a suitable statisti-
cal procedure to test if there are significant differences between them. The t-test 
provides a simple check on accuracy and the F-test on precision. These tests require 
the knowledge of what is known as the number of degrees of freedom.
7. Conclusion
Pharmaceutical products must be analyzed regularly to ensure their safety and 
effectiveness. This chapter described the quality assurance and quality control of 
materials and finished products. The requirements to develop a suitable method and 
its validation. Also different analytical methods and their application in the field of 
pharmaceutical analysis was also discussed.
Conflict of interest
The author declares that there is no conflict of interest.
Author details
Shaza W. Shantier
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of 
Khartoum, Sudan
*Address all correspondence to: sshantier@yahoo.com
© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
17
Drug Analysis
DOI: http://dx.doi.org/10.5772/intechopen.88739
References
[1] Blass B. Basic Principles of Drug 
Discovery and Development. 1st ed. 
Amsterdam: Academic Press; 2015
[2] Cairns D. Essentials of 
Pharmaceutical Chemistry. 3rd ed. UK: 
Pharmaceutical Press; 2008
[3] Jeffery GH, Bassett J, Mendham J,  
Denney RC. Vogel’s Textbook of 
Quantitative Chemical Analysis. 5th ed. 
England, UK: Longman Scientific and 
Technical; 1989
[4] Aulton ME. The Science of Dosage 
Forms Design. 2nd ed. Toronto: 
Churchill Livingstoe; 2002. p. 129
[5] Florence AT, Attwood D.  
Physicochemical Properties of 
Pharmacy, Chapter 4. 4th ed. Chicago, 
London: Pharmaceutical Press; 2006
[6] Genaro AR. Remington, The Science 
and Practice of Pharmacy. 20th ed. 
Philadelphia: Lippincott Williams and 
Wilkins; 2000. p. 986
[7] Ansel HC, Popovich NG, Allen LV.  
Pharmaceuticals Dosage Forms 
and Drug Delivery Systems. 6th ed. 
Philadelphia: Williams and Wilkins; 
1995. p. 117
[8] Lund W. The Pharmaceutical 
Codex. Principles and Practice of 
Pharmaceutics. 12th ed. London: 
Pharmaceutical Press; 1994. pp. 69, 277, 
283
[9] Carstensen JT. Drug Stability 
Principles and Practices. 2nd ed. 
New York: Marcel Deckker; 1995. p. 91
[10] Grossweiner LI. Photophysics. 
In: Smith KC, editor. The Science of 
Photobiology. New York: Plenum Press; 
1989. p. 12
[11] Cadet J, Anselmino C, Douki T, 
Voituriez L. Photochemistry of nucleic 
acid in cells. Journal of Photochemistry 
and Photobiology B: Biology. 
1992;15:277
[12] Albini A, Fasani E. Drugs 
Photochemistry and Photostability. 
Cambridge: The Royal Society of 
Chemistry; 1998. pp. 29, 54, 132, 171
[13] Greenhill JV, McLelland MA.  
Photodecomposition of drugs. 
Progress in Medicinal Chemistry. 
1990;27:51-121
[14] Tonnesen HH. Photostability of 
Drugs and Drug Formulations. London: 
Tylor and Francis; 1996. pp. 5-121
[15] Beckett AH, Stenlake JB. Practical 
Pharmaceutical Chemistry. 4th ed. UK: 
Athlone Press; 2004. pp. 260, 296-300
[16] Shantier SW, Gadkariem EA, 
Ibrahim KAE. A colorimetric method 
for the determination of 
tobramycin. International Journal 
of Drug Formulation and Research. 
2011;2(4):260-272
[17] Shantier SW, Gadkriem EA.  
Colorimetric methods for determination 
of cefquinome sulphate. American 
Journal of Applied Sciences. 
2014;11(2):202-206
[18] Anthony CM, Widdop B, Moss MS.  
Clarck’s Isolation and Identification of 
Drugs. 2nd ed. UK: The Pharmaceutical 
Press; 2006
[19] Shantier SW, Gadkriem EA, 
Adam MO, Mohamed MA. Development 
of stability-indicating methods for 
cefquinome sulphate. International 
Journal of Biomedical Sciences. 
2013;9(3):161-167
[20] Elimam MM, Shantier SW, 
Gadkariem EA, Mohamed MA. Derivative 
spectrophotometric methods for 
the analysis and stability studies of 
Pharmaceutical Formulation Design - Recent Practices
18
colistin sulphate. Journal of Chemistry. 
2015;2015:5. Article ID 624316
[21] Davidson AG, Hassan SV. Assay of 
benzenoid drugs in tablet and capsule 
formulations by second-derivative 
ultraviolet spectrophotometry. 
Journal of Pharmaceutical Sciences. 
1984;73:413
[22] Abounassif MA. pH-Induced 
difference spectrophotometric assay of 
bromazepam. Journal de Pharmacie de 
Belgique. 1989;44:329
[23] Shantier SW, Gadkriem EA. Differential 
spectrophotometric method for 
determination of cefquinome sulphate. 
British Journal of Pharmaceutical 
Research. 2014;4(5):617-625
[24] Yuri K, Rosario L. HPLC for 
Pharmaceutical Scientists. Hoboken, 
New Jersey: John Wiley and Sons; 2007
[25] Veronika RM. Practical High-
Performance Liquid Chromatography. 
3rd ed. New York: John Wiley and Sons; 
1999. p. 15
[26] Watson DG. Pharmaceutical 
Analysis. 2nd ed. UK: Harcourt 
Publishers Limited; 1999. pp. 80, 90-92, 
238, 278
[27] Harvey D. Modern Analytical 
Chemistry. USA: The McGraw-Hill 
Companies; 2000. p. 38
[28] ICH Harmonized Tripartite 
Guideline, Stability Testing of New 
Drug Substances and Products; 2003. 
pp. 1-15
[29] Miller JC, Miller JN. Statistics 
and Chemometrics for Analytical 
Chemistry. 5th ed. England: Pearson 
Education; 2005
[30] Robinson JW. Undergraduate 
Instrumental Analysis. 5th ed. 
New York, Basel: Marcel Dekker; 1995. 
p. 16
